Study of a Device to Relieve Mosquito Bite Itching.
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00822575 |
Recruitment Status :
Completed
First Posted : January 14, 2009
Last Update Posted : January 14, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Mosquito Bites | Device: ZapperClick | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Relief From Itching of Mosquito Bites Clinical Study Protocol. |
Study Start Date : | April 2008 |
Actual Primary Completion Date : | June 2008 |
Actual Study Completion Date : | June 2008 |

Arm | Intervention/treatment |
---|---|
Active Comparator: A |
Device: ZapperClick
The ZapperClick is a therapeutic device that employs the piezo-electricity principle to soothe itching and ease the swelling from mosquito and horsefly bites as well as jellyfish and nettle stings. It accomplishes this by discharging 13KV at 0.7mA for 10 microseconds over the area of the bite or sting each time it is activated. |
Sham Comparator: B |
Device: ZapperClick
The ZapperClick is a therapeutic device that employs the piezo-electricity principle to soothe itching and ease the swelling from mosquito and horsefly bites as well as jellyfish and nettle stings. It accomplishes this by discharging 13KV at 0.7mA for 10 microseconds over the area of the bite or sting each time it is activated. |
- Change in degree of itching rating on a 0-100 VAS. [ Time Frame: 10 minutes ]
- Changes in 0-100 VAS itching ratings, and changes in total area of mosquito bite erythema, across the 24-hour evaluation period. [ Time Frame: 24 hours ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- One lab-induced mosquito bite on the non-dominant forearm
- Familiarity with an immediate mosquito bite reaction.
- History of immediately responding to mosquito bites with itching.
- Willing and able to refrain from consuming anti-histamines, corticosteroids, or Non-Steroid Anti-Inflammatory Drugs (NSAID,) for a time period of 4 half lives of the drug prior to the beginning of the study, and continuing throughout the course of the study.
- Willing to abstain from the use of insect repellant and/or any treatment other than the test device for the relief of mosquito bite symptoms until after the study.
- Primary written and spoken language is English.
Exclusion Criteria:
- No history of prior affliction with mosquito bites.
- History of lack of reaction to mosquito and/or other insect bites that includes itching.
- History of hypersensitivity to the bites or stings of mosquitoes, bees or wasps.
- Presence of mosquito bites or other types of insect bite/stings on any location on the body.
- Current use of steroids.
- Use of insect repellants during the week prior to study start.
- Use of topical agents on the arm during the week prior to study start.
- Pacemaker, ICD or other implantable heart device.
- Therapeutic use of any type of electrical stimulation.
- Epilepsy.
- Diabetes.
- Presence of neurological disorder.
- Prior surgery to the forearm area.
- Infection or wound in the forearm area.
- Any skin or other disease or illness that can cause or influence skin itching, such as Psoriasis.
- Developmental disability or cognitive impairment that impacts the ability to read and/or to understand the content of the informed consent form or the device labeling and/or impacts the ability to read and/or to understand and/or to complete the study case report forms.
- Significant psychological disorder(s) for which treatment has become necessary, including anxiety and depression; psychiatric hospitalization.
- Pregnancy or lactation.
- Involvement in litigation and/or receiving disability benefits related to any kind of disability, injury, or other medical problem.
- Participation in research over the preceding 90 days.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00822575
United Kingdom | |
Department of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, | |
London, United Kingdom, WC 1E 7HT |
Principal Investigator: | Nigel Hill, Ph.D. | London School of Hygiene and Tropical Medicine |
Responsible Party: | Mr. Robin Baker, EcoBrands, Ltd. |
ClinicalTrials.gov Identifier: | NCT00822575 |
Other Study ID Numbers: |
ZC-001 |
First Posted: | January 14, 2009 Key Record Dates |
Last Update Posted: | January 14, 2009 |
Last Verified: | January 2009 |
mosquito bites itching |
Pruritus Skin Diseases Skin Manifestations |